Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific Y-encoded-like protein 5 (TSPYL5) is a member of the TSPY-like protein family with a nucleosome assembly protein (NAP)-like domain, predominantly characterized as an intrinsically disordered protein[2]. TSPYL5 localizes to both nucleus (notably nucleolus) and cytoplasm, with localization governed by distinct sequence motifs. The protein functions as a chaperone for histones and ribosomal proteins, may participate in chromatin remodeling, and is implicated in regulating transcription, cell growth, and stress responses. Notably, TSPYL5 interacts with the tumor suppressor p53, modulating its ubiquitination, sumoylation, and cellular localization—thus potentially promoting oncogenic processes in cancers exhibiting cytoplasmic sequestration of p53[5]. TSPYL5 has emerging relevance as a marker and possible therapeutic target in oncology, though no current drugs directly target it[2][4][5].
Not determined for drugs; mechanistically, TSPYL5 modulates cell growth, p53 function, and AKT pathway signaling, suggesting possible mechanisms for future therapeutics[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific Y-encoded-like protein 5 (TSPYL5).